Aeon Biopharma Shares Fall After Pricing of $20 Million Public Offering

MT Newswires Live

Jan 06, 2025

Aeon Biopharma's (AEON) shares fell more than 66% in recent Monday trading after the company priced a firm commitment underwritten public offering to raise gross proceeds of $20 million.

The offering includes 40 million common units priced at $0.50 each, with each unit comprised one share or a pre-funded warrant, along with series A and B registered common warrants, both exercisable at $0.625.

The company said it granted Aegis Capital a 45-day over-allotment option for up to 15% additional shares and warrants.

Aeon plans to use the use the proceeds for general corporate purposes and working capital.

The offering is expected to close on or about Tuesday.

Price: 0.17, Change: -0.40, Percent Change: -69.60

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2501187256"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501187256\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501187256?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501187256","market":"us","top_or_hot":-1,"title":"Aeon Biopharma Shares Fall After Pricing of $20 Million Public Offering","media":"MT Newswires Live","content":"<html><body><p> Aeon Biopharma's (AEON) shares fell more than 66% in recent Monday trading after the company priced a firm commitment underwritten public offering to raise gross proceeds of $20 million.</p><p>The offering includes 40 million common units priced at $0.50 each, with  each unit comprised one share or a pre-funded warrant, along with series A and B registered common warrants, both exercisable at $0.625.</p><p>The company said it granted Aegis Capital a 45-day over-allotment option for up to 15% additional shares and warrants.</p><p>Aeon plans to use the use the proceeds for general corporate purposes and working capital.</p><p>The offering is expected to close on or about Tuesday.</p><p>Price: 0.17, Change: -0.40, Percent Change: -69.60</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aeon Biopharma Shares Fall After Pricing of $20 Million Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAeon Biopharma Shares Fall After Pricing of $20 Million Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-06 23:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Aeon Biopharma's (AEON) shares fell more than 66% in recent Monday trading after the company priced a firm commitment underwritten public offering to raise gross proceeds of $20 million.</p><p>The offering includes 40 million common units priced at $0.50 each, with  each unit comprised one share or a pre-funded warrant, along with series A and B registered common warrants, both exercisable at $0.625.</p><p>The company said it granted Aegis Capital a 45-day over-allotment option for up to 15% additional shares and warrants.</p><p>Aeon plans to use the use the proceeds for general corporate purposes and working capital.</p><p>The offering is expected to close on or about Tuesday.</p><p>Price: 0.17, Change: -0.40, Percent Change: -69.60</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501187256","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501187256","pubTimestamp":1736177465,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Aeon Biopharma's  shares fell more than 66% in recent Monday trading after the company priced a firm commitment underwritten public offering to raise gross proceeds of $20 million.The offering includes 40 million common units priced at $0.50 each, with  each unit comprised one share or a pre-funded warrant, along with series A and B registered common warrants, both exercisable at $0.625.The company said it granted Aegis Capital a 45-day over-allotment option for up to 15% additional shares and warrants.Aeon plans to use the use the proceeds for general corporate purposes and working capital.The offering is expected to close on or about Tuesday.Price: 0.17, Change: -0.40, Percent Change: -69.60","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","AEON":"AEON Biopharma"},"translate_title":"Aeon Biopharma公开发行2000万美元后股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AEON":0.9},"content_text":"Aeon Biopharma's (AEON) shares fell more than 66% in recent Monday trading after the company priced a firm commitment underwritten public offering to raise gross proceeds of $20 million.The offering includes 40 million common units priced at $0.50 each, with  each unit comprised one share or a pre-funded warrant, along with series A and B registered common warrants, both exercisable at $0.625.The company said it granted Aegis Capital a 45-day over-allotment option for up to 15% additional shares and warrants.Aeon plans to use the use the proceeds for general corporate purposes and working capital.The offering is expected to close on or about Tuesday.Price: 0.17, Change: -0.40, Percent Change: -69.60","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}